Table 2 Hepatologists’ attitude towards the use of serum markers for diagnosis of significant fibrosis and cirrhosis
Variable | Patients (n = 573) |
|---|---|
Do you know non-invasive (blood/serum) fibrosis markers for assessment of hepatic fibrosis? % | |
Extremely likely (100%) | 42.46 |
Very likely (75%) | 35.88 |
Moderately likely (50%) | 13.59 |
Slightly likely (25%) | 6.37 |
Not at all likely (0%) | 1.70 |
Do you think non-invasive (blood/serum) fibrosis markers for assessment of hepatic fibrosis are reliable? % | |
Extremely likely (100%) | 3.82 |
Very likely (75%) | 33.97 |
Moderately likely (50%) | 47.56 |
Slightly likely (25%) | 12.95 |
Not at all likely (0%) | 1.70 |
Do you think non-invasive blood/serum fibrosis markers “biomarkers” for assessment of hepatic fibrosis are acceptable by patients? % | |
Extremely likely (100%) | 43.95 |
Very likely (75%) | 40.13 |
Moderately likely (50%) | 12.31 |
Slightly likely (25%) | 2.76 |
Not at all likely (0%) | 0.85 |
Do you use non-invasive blood/serum fibrosis markers “biomarkers” for assessment of hepatic fibrosis? % | |
Extremely likely (100%) | 15.92 |
Very likely (75%) | 22.29 |
Moderately likely (50%) | 19.75 |
Slightly likely (25%) | 23.57 |
Not at all likely (0%) | 18.47 |
Which non-invasive methods for assessment of hepatic fibrosis do you use? Please choose all that apply % | |
Blood/serum biomarkers | 31.42 |
Transient elastography | 66.24 |
Biomarkers and elastography | 45.01 |
Magnetic resonance elastography | 7.86 |